Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Chubb
Healthtrust
US Army
Fish and Richardson
Boehringer Ingelheim

Generated: September 19, 2019

DrugPatentWatch Database Preview

NALTREXONE HYDROCHLORIDE Drug Profile

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which patents cover Naltrexone Hydrochloride, and when can generic versions of Naltrexone Hydrochloride launch?

Naltrexone Hydrochloride is a drug marketed by Accord Hlthcare, Apotex Inc, Barr, Elite Labs, Fosun Pharma, Specgx Llc, and Sun Pharm. and is included in seven NDAs.

The generic ingredient in NALTREXONE HYDROCHLORIDE is naltrexone hydrochloride. There are nineteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the naltrexone hydrochloride profile page.

Drug patent expirations by year for NALTREXONE HYDROCHLORIDE
Pharmacology for NALTREXONE HYDROCHLORIDE
Drug ClassOpioid Antagonist
Mechanism of ActionOpioid Antagonists
Synonyms for NALTREXONE HYDROCHLORIDE
(-)-Naltrexone
(-)naltrexone
(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7,9,11(18)-trien-14-one
(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one
(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one hydrochloride
(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0;{1,13}.0;{5,17}.0;{7,18}]octadeca-7(18),8,10-trien-14-one
(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-bis(oxidanyl)-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one hydrochloride
(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
(5|A)-17-(Cyclopropyl-methyl-d3)-4,5-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride
(5a)-17-(Cyclopropyl-methyl-d3)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride
(5alpha,17R)-17-(cyclopropylmethyl)-3,14-dihydroxy-6-oxo-4,5-epoxymorphinan-17-ium chloride
(5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride
16590-41-3
16676-29-2
17-(cyclopropylmethyl)-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one hydrochloride
17-(Cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-morphinan-6-one hydrochloride
17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxmorphinan-6-one, (5.alpha.)-
17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one
17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride
17-Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride
3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan-6-one
5S6W795CQM
676N292
88088-EP2270005A1
88088-EP2275420A1
88088-EP2298761A1
88088-EP2298776A1
88088-EP2305648A1
AB00174152_17
AB00174152-14
AB2000507
AKOS015994596
AKOS015994597
AN-12941
Antaxone
AOB5051
API0003491
BCP07022
BCP08343
BDBM50000787
BDBM60212
BIDD:GT0405
BPBio1_000146
BRD-K88172511-003-21-1
BRD-K88172511-310-03-8
BRN 3596648
BSPBio_000132
C-52958
C07253
CAS-16590-41-3
CCRIS 1168
CCRIS 3506
Celupan
CHEBI:134687
CHEBI:7465
CHEMBL1201149
CHEMBL19019
cid_5485201
CS-0763
CS-0880
cyclopropylmethyl(dihydroxy)[?]one
D02095
D05113
DB00704
Depade
DQCKKXVULJGBQN-XFWGSAIBSA-N
DSSTox_CID_26313
DSSTox_GSID_46313
DSSTox_RID_81532
DTXSID4046313
EBD53136
EINECS 240-649-9
EINECS 240-723-0
En 1639A
EN-1639A
EN-1639A [AS HYDROCHLORIDE]
FT-0672602
FT-0696752
GTPL1639
HMS2089O11
HS-0002
HS-0003
HSDB 6750
HY-76710
HY-76711
KS-00000XJR
LS-92094
LS-92096
MCULE-7032963403
MCULE-8888771893
MFCD00069324
MLS000069607
MLS001076516
MLS002153483
MLS002695940
MolPort-004-920-221
MolPort-004-964-109
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-, hydrochloride
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-alpha-oxy-3,14-dihydoxy-, hydrochloride
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5alpha)-
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, hydrochloride, (5-alpha)-
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, hydrochloride, (5alpha)-
Morphinan-6-one,17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5a)-
MorViva
N-Cyclopropylmethyl-14-hydroxydihydromorphinone
N-Cyclopropylmethyl-noroxymorphone hydrochloride
N-Cyclopropylmethylnoroxymorphone
N-Cyclopropylmethylnoroxymorphone hydrochloride
Nalorex
Naltrel
Naltrexon
Naltrexona
Naltrexona [INN-Spanish]
naltrexone
Naltrexone (Hydrochloride)
naltrexone (ReVia)
Naltrexone (USAN/INN)
Naltrexone [USAN:BAN:INN]
Naltrexone [USAN:INN:BAN]
Naltrexone base anhydrous
Naltrexone Depot
Naltrexone Hcl
Naltrexone hydrochloride (USP)
Naltrexone hydrochloride [USAN]
Naltrexone hydrochloride [USP]
Naltrexone Hydrochloride 1.0 mg/ml in Methanol (as free base)
Naltrexone hydrochloride, European Pharmacopoeia (EP) Reference Standard
naltrexone monohydrochloride
Naltrexone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
naltrexone.HCl
Naltrexonum
Naltrexonum [INN-Latin]
NC00693
NCGC00024427-03
NCGC00024427-04
NCGC00024427-05
NCGC00162274-02
Nemexin
NIH 8503
Opera_ID_1828
PDSP2_000847
Prestwick_348
Prestwick0_000116
Prestwick1_000116
Prestwick2_000116
Prestwick3_000116
PTI-555
PTI-901
PubChem24168
ReVia
ReVia (TN)
RHBRMCOKKKZVRY-ITLPAZOVSA-N
s2103
SC-94535
SCHEMBL34681
SCHEMBL37713
SMP1_000206
SMR000058767
SPBio_002071
SW196619-3
Tox21_112007
Tox21_112007_1
Trexan
UM-792
UNII-5S6W795CQM
UNII-Z6375YW9SF
US9107954, naltrexone
Vivitrex
Vivitrol
Vivitrol (TN)
VP-004
W-5065
W-5099
XR-NTX
Z1558290144
Z6375YW9SF
ZINC1773

US Patents and Regulatory Information for NALTREXONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 091205-001 Aug 17, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Specgx Llc NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 076264-002 Mar 22, 2002 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Elite Labs NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 075274-001 May 26, 1999 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Specgx Llc NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 076264-003 Mar 22, 2002 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex Inc NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 207905-001 Jul 21, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Barr NALTREXONE HYDROCHLORIDE naltrexone hydrochloride TABLET;ORAL 074918-001 May 8, 1998 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Baxter
Harvard Business School
US Army
Medtronic
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.